HEPA(HEPA)
HEPA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | — | — |
| Low | — | — |
| High | — | — |
| EBITDA Avg | — | — |
| Low | — | — |
| High | — | — |
| EBIT Avg | — | — |
| Low | — | — |
| High | — | — |
| Net Income Avg | $-4.44B | $-4.40B |
| Low | $-4.44B | $-4.40B |
| High | $-4.44B | $-4.40B |
| EPS Avg | $-472.00 | $-468.00 |
| Low | $-472.00 | $-468.00 |
| High | $-472.00 | $-468.00 |
| Analysts (Rev / EPS) | — / 1 | — / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBITDA Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| EBIT Avg | — | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — | — |
| Net Income Avg | $-2.32B | $-2.21B | $-2.21B | $-1.45B | $-1.05B | $-3.02B | $-1.98B | $-1.34B |
| Low | $-2.32B | $-2.21B | $-2.21B | $-1.45B | $-1.05B | $-3.02B | $-1.98B | $-1.34B |
| High | $-2.32B | $-2.21B | $-2.21B | $-1.45B | $-1.05B | $-3.02B | $-1.98B | $-1.34B |
| EPS Avg | $-200.00 | $-190.00 | $-190.00 | $-125.00 | $-90.00 | $-260.00 | $-170.00 | $-115.00 |
| Low | $-200.00 | $-190.00 | $-190.00 | $-125.00 | $-90.00 | $-260.00 | $-170.00 | $-115.00 |
| High | $-200.00 | $-190.00 | $-190.00 | $-125.00 | $-90.00 | $-260.00 | $-170.00 | $-115.00 |
| Analysts (Rev / EPS) | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 | — / 1 |